Search for: "WARNER CHILCOTT (US), INC." Results 1 - 20 of 28
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Apr 2010, 9:36 pm by Patent Docs
Warner Chilcott Co. [read post]
31 Dec 2015, 8:16 pm by Patent Docs
Warner Chilcott (US), LLC et al. v. [read post]
13 Dec 2011, 5:39 am by Lawrence B. Ebert
In other words, the court’s primary focus was on the question of whether Warner Chilcott was likely to succeed on the merits of its infringement claim, a question which turned on a battle of experts. [read post]
22 Mar 2009, 8:52 pm
Warner Chilcott Laboratories Ireland Ltd. et al. v. [read post]
29 Aug 2011, 7:56 am by Sonya Hubbard
Prior to that, he spent 17 years with Warner-Lambert, which is now part of Pfizer, Inc. [read post]
12 Dec 2011, 1:28 pm
Warner Chilcott and Mayne Pharma International v. [read post]
24 Dec 2008, 3:00 pm
Apotex, Inc (Managing Intellectual Property)     [read post]
25 Jul 2011, 10:48 am by admin
Bisphosphonates for the treatment and prevention of osteoporosis include: FOSAMAX (alendronate sodium) tablets and solution and FOSAMAX PLUS D (alendronate sodium/cholecalciferol) tablets, Merck & Co., Inc.; ACTONEL (risedronate sodium) tablets, ATELVIA (risedronate sodium) delayed release tablets, and ACTONEL WITH CALCIUM (Copackaged) (risedronate sodium with calcium carbonate) tablets, Warner Chilcott, LLC; BONIVA (ibandronate sodium) tablets and injection, Roche… [read post]
8 May 2009, 8:00 am
(Property intangible) US: Supreme Court rules 9-0 that CAFC has jurisdiction to review case remanded by district court to state court: Carlsbad Technology Inc v HIF Bio, Inc et al (Managing Intellectual Property) (Patently-O) US: Anticipation by a laundry list of prophetic DNA sequences: In re Gleave (Holman's Biotech IP Blog) US: Reverse payment settlements and biotechnology (Holman's Biotech IP Blog) US: Biogen seeks review and… [read post]
8 Sep 2011, 11:04 am by Tom Lamb
According to the FDA's Announcement for this September 2011 meeting, these two advisory committees will consider the benefits and risks of long-term use of osteoporosis medications in the bisphosphonate class of drugs, which were identified by the FDA as: FOSAMAX (alendronate sodium) tablets and solution and FOSAMAX PLUS D (alendronate sodium/cholecalciferol) tablets, Merck & Co., Inc.; ACTONEL (risedronate sodium) tablets, ATELVIA (risedronate sodium) delayed… [read post]
10 Feb 2010, 4:47 pm
(Patent Docs) Doryx (Doxycycline) – US: Warner Chilcott files patent infringement suit against Sandoz in response to Para IV challenge (Patent Docs) Ebixa (Memantine) – Canada: Duty of good faith patent prosecution: Lundbeck v Ratiopharm (IP Osgoode) Focalin (Dexmethylphenidate) - US: Settlement announced in Focalin infringement dispute involving Celgene, Novartis Pharmaceuticals and Teva Pharmaceuticals (Patent Docs) Gemzar (Gemcitabine) –… [read post]
25 Jun 2010, 1:28 pm by Tom Lamb
We start with a June 24, 2010 Wall Street Journal article, "WellPoint's Data Led It To Limit Use Of Drug Boniva Article", from we learn that the largest U.S. managed care business in terms of membership, WellPoint Inc., has found through internal research that the osteoporosis drug Boniva, which is marketed by Roche Holding AG's Genentech and GlaxoSmithKline PLC, is linked to higher fracture rates than two other bisphosphonates, Actonel, marketed by… [read post]
15 Apr 2010, 4:27 am
(Spicy IP) Argentina: Argentina’s scientific data laws and TRIPs compliance (IP tango) Chile: Secretary General of International Seed Federation visits Chile, pressures nation to sign UPOV 91 (IP tango) EU: AHP Manufacturing BV v Bureau voor de Industriële Eigendom analysis now in print (The SPC Blog) Hungary: Metropolitan Appeal Court: Preliminary injunction refused concerning combination patent (EPLAW) Hungary: Metropolitan Appeal Court of Budapest upholds decision of Metropolitan… [read post]
9 Jul 2020, 10:56 am by Seeger Weiss LLP
Warner Chilcott plc, et al., in which $125 million was recovered in connection with a sprawling healthcare scheme. [read post]
9 Jul 2020, 10:56 am by Seeger Weiss LLP
Warner Chilcott plc, et al., in which $125 million was recovered in connection with a sprawling healthcare scheme. [read post]
15 Jun 2011, 4:56 am by Marie Louise
(Patent Docs) Gemzar (Gemcitabine) – ALJ Rogers rules on motion to quash in Certain Gemcitabine (337-TA-766) (ITC Law Blog) Oestrin 24 Fe (Norethindrone acetate, Ethinyl estradiol) – US: Patent infringement complaint filed in response to Para IV certification: Warner Chilcott Co. v. [read post]
7 Sep 2011, 4:22 am by Marie Louise
  Highlights this week included: US: CAFC: Immunisation methods are patent eligible: Classen Immunotherapies, Inc v Biogen IDEC et al (Inventive Step) (Orange Book Blog) (Patently-O) (Patent Docs) (Patent Docs) (IPBiz) (Patent Law Practice Center) (Patent Baristas) US: FTC issues long-awaited final report on authorized generics; report examines both the short-term effects and long-term impact on competition and drug prices (FDA Law Blog) (Orange Book Blog)  … [read post]